Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Ideas for Combating Pharma Price Gouging

By Cedric Dark, MD, MPH; and Demetrio An Munoz | on June 12, 2018 | 0 Comment
Policy Rx
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Combat Pharma Price GougingHalf of all Americans in a recent Gallup Poll had a somewhat negative or very negative view of the pharmaceutical industry.1 With the actions of executives like Martin Shkreli (the founder of Turing Pharmaceuticals who drew heavy criticism for instituting large prince increases on Daraprim), drug shortages ranging from atropine to vecuronium, and the unacceptably high prices of older medications such as colchicine, who can blame them?2 Large majorities of Americans agree that the pharmaceutical industry’s prices are too high, that their profits are too large, and that there are many ways to curb these costs.3

You Might Also Like
  • Determining a Fair Price for Health Care
  • U.S. Senators Question Kaleo’ $4,500 Tag on Opioid Overdose Treatment
  • The Democratic Presidential Candidate Front-Runners’ Health Care Plans
Explore This Issue
ACEP Now: Vol 37 – No 06 – June 2018

Some of these broader solutions that are supported by a majority of Americans include allowing the federal government to negotiate pharmaceutical prices for Medicare Part D beneficiaries, making it easier for generics to enter the market, allowing importation of less-expensive drugs from Canada, and eliminating some pharmaceutical advertising, such as the direct-to-consumer ads, which arguably increase patient demand for medications they may not even need.

Even though pharmaceuticals make up only about 10 percent of overall health care costs, they represent one of the most rapidly rising sectors for health care cost growth. Thus, it is imperative that we act now before drug costs swallow the remaining slices of the health care pie. Unlike physician Medicare costs, which arbitrarily could come crashing down due to price controls via sequestration rules and/or payment reform, there is no immediate check to the rise of pharmaceutical prices. Historically, drug companies have only been subject to what the market will bear.

A recent article on the Emergency Medicine Residents’ Association website, reprinted below with permission, discusses why pharmaceutical prices are so high and offers solutions that even the clinician at the bedside can undertake to fight the war on drug prices.


Cedric Dark, MD, MPHDr. Dark is assistant professor of emergency medicine at Baylor College of Medicine in Houston and executive editor of PolicyRx.

References

  1. Healthcare system. Gallup website. Accessed May 23, 2018.
  2. Current drug shortages. American Society of Health-System Pharmacists website. Accessed May 23, 2018.
  3. Public opinion on prescription drugs and their prices. Kaiser Family Foundation website. Accessed May 23, 2018.

Physicians Can Take Steps to Limit Pharma Price-Gouging

The cost of prescription drugs in the United States is constantly in the news, with the public becoming aware of increasing prices for off-patent drugs from the obscure Daraprim (up almost 5500 percent overnight from $13.50 to $700 per capsule) to the universally known epinephrine (up almost 550 percent from $94 in 2007 to $609 in 2016 for a set of two EpiPens).1,2

Pages: 1 2 3 | Single Page

Topics: AdvocacyCost of CareDrug CostPharmaceutical CompaniesPublic Policy

Related

  • Pros and Cons: A Mandated Four-Year Residency

    June 11, 2025 - 1 Comment
  • ACEP 2025 Leadership & Advocacy Conference—Showing Up on Behalf of EM!

    June 5, 2025 - 0 Comment
  • June 2025 News from the College

    June 5, 2025 - 0 Comment

Current Issue

ACEP Now: June 2025 (Digital)

Read More

No Responses to “Ideas for Combating Pharma Price Gouging”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603